DENALI ADVISORS LLC

Position in PAHC — Phibro Animal Health Corp

CIK 1142941 SAN DIEGO, CA

Position in PAHC

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$882,139

+$410,413 QoQ

Shares Held

15,949

-27.2% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 22.571948084519406.ToString("F0")% Shared 0.ToString("F0")% None 77.4280519154806.ToString("F0")%

Healthcare · as of Mar 31, 2026

DENALI ADVISORS LLC holds $9,330,188 across 4 Drug Manufacturers - Specialty & Generic names. PAHC ranks #4 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMPH	Amphastar Pharmaceuticals, Inc.	266,465	$5,220,049
2	SIGA	Siga Technologies Inc	436,887	$2,337,345
3	UTHR	UNITED THERAPEUTICS Corp	1,502	$890,655
4	PAHC	Phibro Animal Health Corp This page	15,949	$882,139

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$882,139	15,949	-27.2%	Shares	Sole	2026-05-08
2021-09-30	$471,726	21,900	-26.8%	Shares	Sole	2021-10-12
2021-06-30	$863,512	29,900	+123.1%	Shares	Sole	2021-08-20
2020-12-31	$260,228	13,400	0.0%	Shares	Sole	2021-01-20
2020-09-30	$233,160	13,400	0.0%	Shares	Sole	2020-10-16
2020-06-30	$352,018	13,400	+67.5%	Shares	Sole	2020-07-23
2020-03-31	$193,360	8,000	—	Shares	Sole	2020-04-23
No filing history on record for this holder in this stock.